The Pharmacologic Treatment of Short Bowel Syndrome: New Tricks and Novel Agents

Matthew L. Bechtold, Stephen A. McClave, Lena B. Palmer, Douglas L. Nguyen, Lindsay M. Urben, Robert G. Martindale, Ryan T Hurt

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.

Original languageEnglish (US)
JournalCurrent Gastroenterology Reports
Volume16
Issue number7
DOIs
StateAccepted/In press - Jul 24 2014
Externally publishedYes

Fingerprint

Short Bowel Syndrome
Intestinal Secretions
Avitaminosis
Parenteral Nutrition
Electrolytes
Intestines
Minerals
Anatomy
Therapeutics
Diet

Keywords

  • Malabsorption
  • Pharmacology
  • Review
  • Small bowel syndrome
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Bechtold, M. L., McClave, S. A., Palmer, L. B., Nguyen, D. L., Urben, L. M., Martindale, R. G., & Hurt, R. T. (Accepted/In press). The Pharmacologic Treatment of Short Bowel Syndrome: New Tricks and Novel Agents. Current Gastroenterology Reports, 16(7). https://doi.org/10.1007/s11894-014-0392-2

The Pharmacologic Treatment of Short Bowel Syndrome : New Tricks and Novel Agents. / Bechtold, Matthew L.; McClave, Stephen A.; Palmer, Lena B.; Nguyen, Douglas L.; Urben, Lindsay M.; Martindale, Robert G.; Hurt, Ryan T.

In: Current Gastroenterology Reports, Vol. 16, No. 7, 24.07.2014.

Research output: Contribution to journalArticle

Bechtold, Matthew L. ; McClave, Stephen A. ; Palmer, Lena B. ; Nguyen, Douglas L. ; Urben, Lindsay M. ; Martindale, Robert G. ; Hurt, Ryan T. / The Pharmacologic Treatment of Short Bowel Syndrome : New Tricks and Novel Agents. In: Current Gastroenterology Reports. 2014 ; Vol. 16, No. 7.
@article{25a2237325044beb84a654ed564087b2,
title = "The Pharmacologic Treatment of Short Bowel Syndrome: New Tricks and Novel Agents",
abstract = "Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.",
keywords = "Malabsorption, Pharmacology, Review, Small bowel syndrome, Treatment",
author = "Bechtold, {Matthew L.} and McClave, {Stephen A.} and Palmer, {Lena B.} and Nguyen, {Douglas L.} and Urben, {Lindsay M.} and Martindale, {Robert G.} and Hurt, {Ryan T}",
year = "2014",
month = "7",
day = "24",
doi = "10.1007/s11894-014-0392-2",
language = "English (US)",
volume = "16",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "7",

}

TY - JOUR

T1 - The Pharmacologic Treatment of Short Bowel Syndrome

T2 - New Tricks and Novel Agents

AU - Bechtold, Matthew L.

AU - McClave, Stephen A.

AU - Palmer, Lena B.

AU - Nguyen, Douglas L.

AU - Urben, Lindsay M.

AU - Martindale, Robert G.

AU - Hurt, Ryan T

PY - 2014/7/24

Y1 - 2014/7/24

N2 - Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.

AB - Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.

KW - Malabsorption

KW - Pharmacology

KW - Review

KW - Small bowel syndrome

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84904535034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904535034&partnerID=8YFLogxK

U2 - 10.1007/s11894-014-0392-2

DO - 10.1007/s11894-014-0392-2

M3 - Article

C2 - 25052938

AN - SCOPUS:84904535034

VL - 16

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 7

ER -